维普中文期刊产品整合服务
685篇 您的检索式:作者名="Jaggi"
    题名 作者 年代 出处 被引量
1Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer显示文摘The goal of this investigation was to develop and demonstrate a polymer/paclitaxel selfassembly(PTX-SA) formulation. Polymer/PTX-SAs were screened based on smaller size of formulation using dynamic light scattering analysis. Additionally, fluorescence microscopy and flow cytometry studies exhibited that polyvinylpyrrolidone(PVP)-based PTX-SAs(PVP/PTX-SAs) had superior cellular internalization capability in MCF7 and MDA-MB-231 breast cancer cells. The optimized PVP/PTXSAs exhibited less toxicity to human red blood cells indicating a suitable formulation for reducing systemic toxicity. The formation of PVP and PTX self-assemblies was confirmed using fluorescence quenching and transmission electron microscopy which indicated that the PVP/PTX-SAs were spherical in shape with an average size range of 53.81 nm as detected by transmission electron microscopy(TEM).FTIR spectral analysis demonstrates incorporation of polymer and paclitaxel functional groups in PVP/PTX-SAs. Both proliferation(MTS) and clonogenic(colony formation) assays were used to validate superior anticancer activity of PVP/PTX-SAs in breast cancer cells over paclitaxel. Such superior anticancer activity was also demonstrated by downregulation of the expression of pro-survival protein(Bcl-x L), upregulation of apoptosis-associated proteins(Bid, Bax, cleaved caspase 7, and cleaved PARP)and β-tubulin stabilization. These results support the hypothesis that PVP/PTX-SAs improved paclitaxel delivery to cancer cells.Pallabita Chowdhury Prashanth K.B.Nagesh Sheema Khan Bilal B.Hafeez Subhash C.Chauhan Meena Jaggi Murali M.Yallapu 2018Acta Pharmaceutica Sinica B2018,8,4:7
2Milk exosomes:Nature’s abundant nanoplatform for theranostic applications显示文摘Exosomes are a unique subpopulation of naturally occurring extracellular vesicles which are smaller intracellular membrane nanoparticle vesicles.Exosomes have proven to be excellent nanocarriers for carrying lipids,proteins,mRNAs,non-coding RNAs,and DNAs,and disseminating long-distance intercellular communications in various biological processes.Among various cell-line or biological fluid derived exosomes,milk exosomes are abundant in nature and exhibit many nanocarrier characteristics favorable for theranostic applications.To be an effective delivery carrier for their clinical translation,exosomes must inbuilt loading,release,targeting,and imaging/tracking characteristics.Considering the unmet gaps of milk exosomes in theranostic technology it is essential to focus the current review on drug delivery and imaging applications.This review delineates the efficiency of exosomes to load therapeutic or imaging agents and their successful delivery approaches.It is emphasized on possible modifications of exosomes towards increasing the stability and delivery of agents.This article also summarizes the specific applications and the process of developing milk exosomes as a future pharmaceutical drug delivery vehicle.Benilde Adriano Nycol M.Cotto Neeraj Chauhan Meena Jaggi Subhash C.Chauhan Murali M.Yallapu 2021Bioactive Materials2021,6,8:2
3Prognostic value of cy- cle exercise testing prior to and after outpatient cardiac rehabilita- tion显示文摘Di Valentino M Maeder MT Jaggi S 2010Int J Cardio]2010,140,1:1
4Pollution disclosures, pollution performance and economic performance显示文摘Freedman M Jaggi B 1982Omega1982,,10:1
5Ordering policies of deteriorating items under permissible delay in payments显示文摘Aggarwal SP Jaggi CK 1995European Journal of the Operational Research1995,46,5:1
6Mechanisms in cancer-chemo- therapeutic drugs-induced peripheral neuropathy显示文摘Jaggi AS Singh N 2012Toxicology2012,291,1:1
7Polynomial time algo- rithms for multicast network code construction显示文摘Jaggi S Sanders P Chou P A 2005IEEE Transactions on Information Theory2005,51,6:1
8An examination of the impact of pollution performance on economic and market performance: pulp and paper firms显示文摘Jaggi B Freedman M 1992Journal of Business Finance and Ac- counting1992,19,5:1
9Retailer's optimal replenishment decisions with credit-linked demand under permissible delay in payments显示文摘Jaggi C K Goyal S K Goel S K 2008European Journal of Operational Research2008,,190:1
10A joint approach for setting unit price and the length of the credit period for a seller when end demand is price sensitive显示文摘Abad P L Jaggi C K 2003International Journal of Production Economics2003,83,:1
11Exploring the potential effect of Ocimum sanctum in vincristine-induced neuropathic pain in rats显示文摘KAUR G JAGGI A S SINGH N 2010J Brachial Plex Peripher Nerve Inj2010,5,:1
12Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-II) in combination with quercetin: possible contribution of P-glycoprotein显示文摘BANSAL T A W ASTHI A JAGGI M 2008Life Sci2008,83,78:1
13Curcumin nanoformulations:a future nanomedicine for cancer显示文摘Yallapu MM Jaggi M Chauhan SC 2012Drug Discovery Today2012,7,12:1
14Animal models of dementia and cognitive dysfunction显示文摘Neha Sodhi RK Jaggi AS 2014Life Sci2014,109,2:1
15Polynomial time algorithms for multicast network code construction显示文摘JAGGI S SANDERS P CHOU P A 2005IEEE Trans on Information Theory2005,51,6:1
16Ameliorative role of Atrovastatin and Pitavastatin in L-Methionine induced vascular dementia in rats 显示文摘Koladiya RU Jaggi AS Singh N 2008BMC Pharmacology2008,8,14:1
17Polynomial time algo- rithms for multicast network coding construction 显示文摘JAGGI S SANDERS P CHOU P A 2005IEEE Trans- actions on Information Theory2005,51,6:1
18Ameliorative effects of Ocimum sanctum in sciatic nerve transection-induced neuropathy in rats显示文摘Muthuraman A Diwan V Jaggi AS Singh N Singh D 2008J Ethnopharmacol2008,120,1:1
19Retailer’s optimal replenishment decisions with credit-linked demand under permissible delay in payments显示文摘Chandra K. Jaggi S.K. Goyal S.K. Goel 2007European Journal of Operational Research2007,,1:1
20Poly(ADP-ribose)polymerases-1 (PARP-1) and its therapeutic implications显示文摘Sodhi R K Nirmal Singh Jaggi A S 2010Vascular Pharmacology2010,53,3:1
返回顶部 每页显示:
共35页 首页 上一页 第1页 下一页 末页 /35 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费